Search

everythinglearnresearchcommunity

for

Search:↓

24-Hydroxycholesterol reduces DHT formation in brain cancer cells, linking cholesterol and hormone metabolism.

Atopic dermatitis needs personalized treatment using various therapies, starting with topical corticosteroids.

Losing both ERBB2 and ERBB3 receptors in mice causes significant skin problems and inflammation.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Neuroactive steroids affect cocaine's rewarding effects through the sigma1 receptor.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Two new compounds were found to effectively reduce hair growth in mice.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Potassium channel modulators mostly increase the activity of rat whisker mechanoreceptors.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

New research on prostamide F2α has led to treatments for glaucoma and eyelash growth and may have more medical uses.

Targeting protein S-palmitoylation could lead to new skin disease treatments.

Inhibiting PLA2 enzymes may help treat inflammatory skin diseases like psoriasis and dermatitis.

The compound improved hair growth and reduced hair loss.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.